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ABSTRACT
Animal models and two-dimensional assays involved in drug testing, vaccine
development and basic scientific discovery are not an accurate representation of the
human body; hence there is a need to develop new bench top methodologies which are
better suited to yield information about in vivo behavior. There is a paucity of reliable in
vitro-derived information regarding the reasons for the cause and progression of diseases.
These concerns have lead to the development of three-dimensional systems which can
facilitate improved understanding of disease etiology and also can bridge the path to the
clinic.
The long term goal, beyond the scope of this project is to develop a threedimensional breast test system which contains different cell types in a spatial
arrangement mimicking that seen in the mammary gland. The primary goal of this project
is to standardize a bioprinter and to analyze cellular interactions, the results of which will
be used to inform the construction of three-dimensional test systems. D1 cells were
printed onto three different substrates, in different concentrations and time intervals, to
study the number of cells ejected per drop. The results indicated a consistent rise in the
number of cells per drop with time and cell concentration, the maximum obtained at a
concentration of 8 million cells/mL. Subsequently, D1 cells and NMuMGs were printed
and pipetted in specific patterns to analyze the effect of the NMuMGs on the
differentiation of D1s. The substrates were chitosan-gelatin-coated, collagen gel-coated
and polystyrene slides. At the end of 16 days, the cells were tested for the presence of
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specific genes and lipids. The lipid analysis data did not indicate significant differences
between the samples that were printed but showed marginally higher lipid production in
the presence of NMuMGs in the pipetted group. The semi-quantitative gene expression
data indicated that a change in intercellular distance between mammary epithelial cells
and murine bone marrow stromal cells influences adipogenesis, with the highest gene
expression of aP-2 when the two cell types were furthest apart

.
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PREFACE
Because animal models and two-dimensional assays involved in drug testing,
vaccine development and basic scientific discovery are not an accurate representation of
the human body, new strategies are being explored. Of particular interest is the
fabrication of a three-dimensional test system with cellular arrangements resembling
specific tissue types seen in vivo. These test systems aim to reduce the number of animal
models used in the study of drug response in vivo at reduced cost and time.
The purpose of the work described in this thesis was to perform the preliminary
tests required to develop a three-dimensional breast tissue test system. Three studies were
carried out. First, the cellular ejection from a bioprinter was standardized, second, a
chitosan based bio-ink was created and third, the influence of murine mammary epithelial
cells (NMuMGs) on the differentiation of murine bone marrow stromal cells was
analyzed using inkjet printing as the cell dispensing tool. The results from this study were
compared to samples where the cells were pipetted on the substrates.
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CHAPTER 1
BACKGROUND
For every new drug discovered, it takes as much as ten years from the time it is
studied in vitro and in animal models, until it is tested in humans. Only one in every 50
drugs entering the pre-clinical testing is deemed acceptable to be tested on humans and
only 20% of the drugs entering clinical testing are granted United States Food and Drug
Administration (US FDA) approval [1, 2]. Also, while significant efforts have been
applied toward developing new therapies, there is lack of sufficient information regarding
the cause for a particular disease. These problems were identified by the US FDA and in
March 2004; the Critical Path Initiative (CPI) was initiated, which focuses on developing
new tools and processes that can be used to assess drugs and medical devices and
evaluate the safety and quality of medical products [3].
Need For A Three-Dimensional Tissue Test System
Tissue engineering has been traditionally applied to develop cellular scaffolds for
tissue or organ repair. It is in recent times that this field has expanded to include the
fabrication of three-dimensional cellular bench top systems (3D systems) which can be
used to answer specific questions. These 3D systems can be used to understand the ‘why’
and ‘how’ of diseases, to study cellular behavior and interactions, and to aid in drug
development.

The norm for drug testing has always been to couple data gleaned from in vitro
two-dimensional cell culture systems with that from animal models. A number of highthroughput two-dimensional (2D) screening assays are used, which address topics such as
cellular toxicity, signal transduction pathways, and proliferation. Once this bench top
testing is complete, the next step is the use of a suitable animal model to test effects and
characteristics such as local and systemic toxicity, dosage, and half-life. A drug that tests
positive for anticancer activity based on data extracted from in vitro systems and animal
models often subsequently fails during clinical trials. For example, the use of endostatin
against three types of tumors resulted in excellent outcomes in animal models; indeed, the
eradication of the tumor tissue coupled with lack of relapse sparked a high level of
interest in this drug. However, results from clinical trials failed to match those from the
animal studies [4]. This inability to match the results obtained from human or mouse
tumors transplanted into immune deficient mice and other animals has made it necessary
to derive additional pre-clinical information. Animal models used for drug testing provide
a lot of insight with respect to drug behavior in an in vivo environment but animal
physiology is very different from human physiology and therefore animal models do not
accurately represent the human tissue system. All of these reasons, coupled with
economic and ethical constraints, have led to a decline in the number of animal models
used in drug testing [5].
Bench top tissue test systems may also be used to improve our understanding of
basic cell biology. The cell behavior during metastasis, for example, has been studied
using tissue test systems. During metastasis, cells use protein digesting enzymes to cleave
2

themselves from a tumor. Using a 3D culture system it has been observed that, upon
blocking these enzymes, the cells change morphology and become amoeba-like,
eventually squeezing through the gaps in the tumor matrix [6]. This type of observation is
not possible to make using a two-dimensional test system. There is considerable
difficulty in studying and comparing the cellular interactions and mechanisms between
different cell types in vivo. Two-dimensional monolayer cultures neither assemble into
the shape nor provide the function of the tissue in question, and are therefore inadequate
systems with which to study these interactions. The growth and morphology of a cell on a
two-dimensional substrate differs considerably from that on a three-dimensional system;
hence, the information regarding cell behavior from a 2D model is not entirely relevant
and cannot be applied as such [7]. All these conditions point towards the use of albeit
complex but physiologically relevant three-dimensional test systems. These 3D systems
do not aim to eliminate the use of animal models, but to obtain more information which
can be applied towards improving animal studies and obtaining enhanced information
from fewer animals.
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Fig 1.1 Scaffold-based Tissue Engineering. Once the scaffold is developed and seeded
with cells, it is cultured in a suitable bioreactor where the necessary environmental
factors and nutrients are supplied to develop the 3D tissue [8].

Some of the initial 3D models were whole animal explant cultures. These explants
have proven useful as they contain the native architecture and cells in the tissue. These
models have been studied to obtain information about the tissue mechanics and cellular
mechanisms. Simple three-dimensional models such as multicellular tissue spheroids
containing different cell types are also currently used in tissue engineering [9]. The
spheroid model is favored in tumor modeling because it captures the morphological
features and also the interactions between cells and that between cell and the matrix. The
varying environment experienced by the cells, depending on their location, is represented
in the spheroid model [10]. Microcarriers, another form of 3D model, are small spheres
with large surface areas available for cell culture. These microcarriers are not only used
to study cell behavior in vitro but can also be delivered in vivo for tissue regeneration.
4

The complex three-dimensional models built with tissue engineering methodologies
include scaffolds [9]. The scaffolds may vary according to chemistry (natural and
synthetic polymers), form (gels, sponges, meshes) and the material properties (elasticity,
stiffness, porosity, degradation rate) [11].
Advantages of Three-Dimensional Models
Two-dimensional models are limited in their scope because they cannot emulate
the complex biochemical and biomechanical in vivo microenvironment. Additionally, 3D
cellular features, e.g. ducts, vasculature, simply cannot be generated in a 2D environment.
Most cells require cues from a 3D environment in order for them to reveal the actual cell
architecture and functions. A flat, artificial 2D surface will provide very different
mechanical and chemical cues, resulting in a misrepresentation of the cell and its in vivo
behavior. A three-dimensional model can provide at least some of the conditions seen in
vivo. Cells cultured on or in a biomaterial experience mechanotransduction i.e.
mechanical signals provided by the surrounding or underlying biomaterial are translated
across the cell membrane, resulting in the production of biochemical signals which in
turn influence cell behavior such as attachment and growth [12]. The mechanical signals
and the interaction between biomaterial and extracellular matrix are very different in 3D
versus 2D. The extracellular matrix also contains signaling molecules which play a role
in cellular processes. The cell-extracellular matrix interactions have been shown to affect
the gene expression of the cell [13]. In a three-dimensional model, the supply of oxygen,
nutrients and other signaling molecules is limited by diffusion through the biomaterial
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scaffold, whereas the supply to cells in a two-dimensional system is uninhibited. Mass
transport plays a role in cell proliferation, and cellular pathology [14], hence another
reason that 2D and 3D tissue systems yield very different cellular behaviors. A threedimensional model provides greater opportunity to study a variety of biological questions
in a more realistic, 3D spatial array.
Breast Tissue Test Systems
Three-dimensional systems that model breast tissue may be used to develop our
understanding of the various cellular mechanisms behind cancer development, its
progression and metastasis, and to develop new therapies for the treatment of breast
cancer. The cellular interactions between the breast cancer cells and the normal
mammary cells can be analyzed using breast tissue test systems. A breast tissue model
should be able to recreate the interactions between the mammary epithelial cells, stromal
cells, adipocytes, fibroblasts, endothelial cells, should have the capability of facilitating
acinar and ductal growth and maintenance within the structure and must also be able to
provide the necessary heterogeneous environment with all the biochemical and physical
cues for each cell type, enabling cells to perform normal physiological functions.
Assembling this complex a model is quite difficult and considerable efforts are being
directed to achieve this end.
Early three-dimensional models involved the cultivation of mammary epithelial
cells on Matrigel or „floating collagen rafts‟ that allowed the assembly of the cells into
structures resembling acini and in the presence of hormone supplemented medium,
6

demonstrated casein synthesis and development [15]. Matrigel, or reconstituted basement
membrane, is a commercially available matrix that contains proteins like collagen and
laminin, which favor cell attachment and proliferation. These models provide important
information, but often lack the compliance essential for anchorage dependent cells to
develop a full range of cellular functions. Additionally, Matrigel contains a high number
of factors, many of which have not been identified, which can cause complications when
attempting to answer very specific biological questions. Furthermore, this gel is highly
variable (both batch to batch and within batch) which causes further logistical issues with
regard to data collection and analysis [16].
The multicellular spheroid model is a commonly used model to study breast
tumor interactions. Spheroid models have been used to study the interactions between
fibroblasts and tumor cells during the formation of scirrhous tumors [17]. Spheroid cocultures of endothelial and tumor cells are valuable for studying the interactions between
the cell types and gaining insight regarding the process of oxygen and nutrient transfer to
the center of the tumor [18]. The spheroid models have also been used to study patterns
of cell adhesion which can influence cell behavior. It has been seen that a reduced
function of E-cadherin can result in metastasis [19]. These spheroid models have also
been used to test the sensitivity of drugs to tumor cells. Cisplatinum is a chemotherapy
drug and, using spheroid models, it has been shown to increase the levels of TGF-β1,
which is indicative of the drug response in vivo [20]. Human MCF-7 breast cancer cells
encapsulated in alginate-poly-l-lysine-alginate microcapsules have been tested as models
for drug testing. The effectiveness of several anticancer drugs was tested with this model
7

and revealed more realistic results as compared with data derived from monolayer
cultures [21].
Naturally-derived polymers such as chitosan and collagen and synthetic polymers
such as polyglycolide and polyethylene terephthalate, have been used to form threedimensional systems. Collagen-hyaluronic acid sponges support the differentiation of
preadipocytes, facilitating mammary tissue development [22]. Silk scaffolds, when
seeded with human adipose derived stem cells, have been shown to support adipogenesis
in vivo for 4 weeks without degradation, thereby providing the necessary structural
integrity [23]. Porous silk scaffolds seeded with human epithelial cells and adipocytes
within a mixture of Matrigel and collagen have been used to study cellular interactions.
The results showed the formation of ductal and alveolar structures, an inhibition in
epithelial cell proliferation, and an increase in adipocyte differentiation[24]. Silk
scaffolds have also supported the formation of adipose tissue with vasculature like
structures when seeded with endothelial cells and stem cells [25].
Synthetic co-polymer scaffolds of polylactide-co-glycolide (PLG) have been
shown to support adipogenesis in vivo, resulting instable volumes of tissue, six weeks
after implantation [26]. Other synthetic polymers such as polyethylene terephthalate have
been shown to favor the differentiation of preadipocytes and stem cells into mature
adipocytes [23, 25]. One of the biggest challenges in creating a breast tissue model is in
creating a heterogeneous environment which can provide the varying physical and
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chemical conditions required by the different cells. This heterogeneity is lacking in many
of the existing tissue models [18].
Four-week co-cultures of epithelial cells and fibroblasts in gel mixtures of
collagen and Matrigel have been shown to form ductal and acinar structures that resemble
those in vivo[7]. This model, though successful in facilitating the formation of these
structures, does not entirely match the in vivo environment because of the random
distribution of cells within the model. The spatial location of cells within a 3D structure is
an integral part in mimicking the breast tissue micro-environment. Even though epithelial
cells have been shown to have the ability to self-assemble into acinar and duct-like
structures, the other cell types which form a part of the normal breast tissue, such as
adipocytes, fibroblasts etc., lack this ability, resulting in architectural limitations in a
three-dimensional model. This poses a problem because these cellular interactions are
essential for the development of normal phenotype and function, the absence of which
can greatly influence cell behavior. Hence, it necessary to probe for methods that move
closer to recreating the microenvironment with the precise placement of cells.
Tissue Microenvironment
To develop a three-dimensional model, it is necessary to understand the
microenvironment surrounding the cell. Biochemical and structural cues influence the
gene expression of a cell, thereby indirectly affecting the cellular processes. In any tissue,
the microenvironment varies throughout the structure and, as a result, the cells experience
different conditions at different locations, resulting in changes in cell behavior within the
9

tissue. Two-dimensional models cannot create this varied microenvironment and hence
are not successful in recreating in vivo cell behavior [27]. For example, mammary
epithelial cells grown in monolayers on collagen gels do not differentiate. However,
when the cells are grown on laminin rich 3D matrix, they form 3D structures similar to
the acini-like structures seen in vivo [28].
The extracellular matrix (ECM) plays an important role; the presence or absence
of factors in the ECM can affect the expression of transforming growth factor-β1, a
regulator of cell proliferation [29]. The presence of lactogenic hormones, for example,
can induce acini-like structures grown on laminin gels to produce milk proteins [30]. The
three-dimensional geometry of the scaffold affects the gene expression and differentiation
of the cell. When polyethylene terephthalate matrices were seeded with preadipocytes,
mature adipocytes were produced without any hormonal induction [31]. The mechanical
and shear forces acting on the tissue also contribute to the cell behavior; for example in
the case of zebra fish, the shear forces caused by blood flow are essential for the normal
phenotypic development of the heart [32].
Cell-cell contact between mammary epithelial cells and MCF-7 breast cancer cells
grown in a coculture, has been shown to cause apoptosis of breast cancer cells. The cells
from a primary tumor can affect the growth of cancer cells at a distant site in the body via
hormone signalling [33]. Cellular interactions with ECM affect the cell response to
cancer therapy; epithelial cells that are polarized have been shown to be resistant to
chemotherapy, due to the specific interactions of β4 integrin with the ECM [34].
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Alterations to the cell microenvironment could result in tumor progression. An increased
expression of specific ECM receptors such as β-1 integrin can induce the progression of
breast cancer [35]. Conversely, antibodies to this receptor can alter the malignancy of
breast cancer cells, reverting the abnormal shape and growth patterns of the cell [6].
Three-dimensional tissue systems are vital to understanding the tissue microenvironment
and the effect that it has on cancer cells.
Conventional Scaffold Fabrication Technologies
Some of the conventional fabrication tools such as solvent casting, gas foaming,
melt molding, freeze drying, and solution casting have processing limitations that result
in variable pore size and geometry as well as shape limitations [36]. Indeed, many of the
processes result in a high level of variability, use toxic solvents and are labor intensive
[37]. Also, the conventional methods of fabrication result in random cell seeding and rely
on self-assembly of the cells into desired shapes. These conventional methods do not
allow complete control over the design of the scaffold, necessitating a search for alternate
fabrication methods. It is likely more effective to position cells at specific locations in a
3D array, enabling the cells to interact with surrounding cells and microenvironment, and
to grow into the desired shapes and structures [38].
A number of advanced fabrication technologies, such as solid freeform techniques
(SFF techniques), are currently being applied to biological applications. These
technologies include photo-polymerization, selective laser sintering, fused deposition
modeling, and 3D printing. These technologies have the advantage of lowered labor costs
11

and time. These SFF techniques use software such as CAD to design the scaffold, thereby
allowing the researcher to control the design and making it possible to create
heterogeneous 3D scaffolds.
Selective laser sintering (SLS) is an SFF technique, where polymer particles are
fused, sometimes incorporating ceramic or other fillers, using heat from a laser beam.
The process is limited by the beam diameter, and the scaffold geometry can be adjusted
by varying the process parameters. This technique has been used to create
poly(methylmethacrylate-co-n-butyl methacrylate)/calcium phosphate bone implants
which have been tested in animals and shown to integrate with host tissue [39]. Some of
the advantages of SLS include the ability to create anisotropic scaffolds and irregular
shapes and sizes. The limitations include the need to use thermally stable polymers at
high processing temperatures [40].
In fused deposition modeling (FDM), the material is extruded through a nozzle
and deposited in layers. In this process, the direction of deposition and the spacing may
be purposefully varied to create structural variations. Materials such as poly(εcaprolactone) have been used to create FDM-processed scaffolds which have been used
for orthopedic applications [41, 42]. FDM generally yields scaffolds with high structural
integrity and mechanical strength as well as porosity that can be varied from structure to
structure. However, it is not possible to create a scaffold with different porosities at
different sections within the structure and requires the use of supporting structures for
complex designs [40].
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Photopolymerization is the process by which light from a laser beam is directed
on specific regions of a liquid polymer to initiate polymerization in those regions. This
process may be repeated to obtain a three-dimensional scaffold. Photopolymerization can
also be used to create hydrogels of materials such as 2-hydrozyethyl methacrylate.
Pressure-assisted microsyringe (PAM) fabrication is a method where polymer dissolved
in a solvent is deposited using a syringe. The solvent acts as a binder, resulting in the
development of a scaffold. The deposition method is similar to FDM; however, scaffolds
formed by PAM fabrication are of greater resolution [43]. Some other fabrication
techniques include 3D bioprinting, theriform, robocasting, and precision extruding
deposition; all the fabrication methods aim to create a unique microenvironment that will
provide the conditions suitable for the growth of cells.
Inkjet Printing Technologies
Bioprinting can be defined as a microfabrication process which enables the layer
by layer deposition of cells and biomaterials to model the in vivo microenvironment, and
is a suitable method for the creation of scaffolds containing cells and other biological
materials [44-46].

Much of the early work with bioprinters has involved printing

biological molecules such as growth factors and other proteins to study cell growth and
differentiation in response to printed biological molecules [47]. Because molecules and
factors are expensive, bioprinting can reduce costs and quantities. Bioprinting
methodology has been used to pattern growth factors such as bone morphogenetic
protein-2 to control osteoblast differentiation in vitro [48]. Growth factors like insulin-
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like growth factor, basic fibroblast growth factor have also been printed to study cellular
response to growth factors and to recreate the stem cell microenvironment [49-51].
However, the focus has now shifted toward the possibility of creating three-dimensional
structures by simultaneously printing the scaffold material and cells [52, 53].
Bioprinters are inkjet printers which can be either drop-on-demand, or continuous
ejection printers [54]. Continuous inkjet printing is one of the methods where liquid flows
through an orifice and breaks into a stream of droplets which are directed into position by
an electric field. The drops that are not used are gathered in a collecting chamber and
recycled. The drop-on-demand inkjet printing generates a drop through a pulse in the
fluid chamber. This drop is generated by a voltage pulse, in the case of piezoelectric
inkjet printing [55, 56]. The thermal inkjet printers operate by heating a portion of the
chamber containing the ink. This heat results in the generation of a bubble which forces
liquid out of the nozzles. Once the drop is ejected, the liquid void created is immediately
filled with ink from the reservoir. Inkjet printers have been used to print mammalian cells
like 3T3 fibroblasts, Chinese hamster ovary cells, endothelial cells, and smooth muscle
cells [52, 56, 57] to create co-culture patterns of neuron and glial cell [58], to pattern
fibronectin on scaffolds for cell positioning [59], etc.
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Fig 1.2 Thermal Inkjet Printer [60].

Inkjet printers have the advantage of being able to print multiple bio-inks at the
same time, thereby making it possible to print more than one material or cell type
simultaneously. The drops printed from the inkjet printer are generally about 50 microns
in radii and are 130 picoliters in volume. Besides inkjet printing is a noncontact printing
method, the printhead does not touch the substrate. Inkjet printing is an inexpensive
method of fabrication [61]. Some of the concerns concerning inkjet printing focus on cell
viability. Mammalian cells are sensitive to heat and stress and may be affected by the
printing process [62]. However, studies with Chinese hamster ovary cells have shown
that less than 10% of the cells are lysed during the printing process, likely because even
though high temperatures are experienced in the nozzles, the time scale involved is not
sufficient for the heat to disperse through the liquid [55]. Also, the mammalian cell
15

volume is very small as compared to the drop volume [63]. Similar cell viability studies
were conducted using piezoelectric printers, where the amplitude of the electric pulse was
changed, and did not result in statistically significant changes in cell viability [56].
Like every fabrication method, bioprinting has its issues. These include nozzle
clogging, bio-ink viscosity limitations, formation of satellite drops, and difficulty in
maintaining pattern fidelity [57, 64]. The rheological properties of the bio-inks must be
modified and refined for printing. The viscosity should be sufficiently low to facilitate the
rapid replenishment of the liquid void created during printing and easy flow through the
nozzles; however, must also be high enough to prevent the ink from dripping through the
nozzles [65]. The acceptable viscosity range in the case of thermal inkjet printers has
been determined to be approximately 1-1.5cps and that of piezoelectric printers to be 510cps. The viscosity has also been found to influence the spreading of the printed drop
and therefore the shape of the printed structure. The use of several viscosity modifiers
such as glycols and diols are being considered to improve the viscosity of bio-inks [66].
During printing, the small drop volume causes the pattern to dry very quickly.
This occurrence poses a problem, particularly when printing onto dry surfaces.
Additionally, a small drop pattern cannot be printed onto a wet surface as it results in
pattern distortion. Use of a hydrogel as the substrate for printing can provide a solution
to this problem. Alginate [46, 57], collagen [58], and fibrin [67, 68] have been used to
form substrates for printing. The presence of satellite drops during printing creates a
problem as it affects pattern resolution. Studies that have used surfactants such as
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Pluronic suggest reduced formation of satellite drops without reduction in cell viability
[69].
To sustain a pattern of viable cells, it is necessary to monitor post printing
treatment; adding medium too quickly can affect pattern retention and adding medium
after a considerable amount of time can affect cell viability. Pattern fidelity and cell
viability can also be affected by addition of medium too early or too late. Nozzle
clogging, which is a common phenomenon with printer inks, is aggravated in case of bioinks. Ink can dry in the nozzle; additionally salt deposits may be formed in the nozzle,
reducing the efficiency of the cartridge [64]. With bio-inks containing cells, cellular
aggregation also poses problems that can lead to nozzle clogging; although, ethylene
diamine tetraacetic acid (EDTA) has been shown to reduce cell clumping and increase
the efficiency of printing [70]. An “off-the-shelf” inkjet printer has the disadvantage of
moving only along the „x‟ axis; the print head cannot move along the „y‟ and the „z‟ axis.
This poses a problem when creating three-dimensional structures of considerable size. To
overcome this barrier, several custom printers have been fabricated which use the same
foundational technology as the inkjet printer. One such custom printer is the PawPrint
biofabricator, which is capable in moving along all three axes and can hold up to 4
cartridges at once making it possible to simultaneously print several bio-inks [71]. In
spite of many current limitations, inkjet printing is still considered a suitable fabrication
system of the future, because this technology makes it possible to create as precise a
microenvironment as possible, with high levels of control over the spatial co-location of
cells.
17

One overarching research goal in the Clemson University Institute for Biological
Interfaces of Engineering is to develop a tissue test system which can be used to study
breast cancer etiology and also serve as a model for drug testing. To develop such a test
system, it is necessary to first determine a suitable substrate which can be readily
modified to satisfy a range of desired physical properties, to determine potential
fabrication technologies, and to understand the interactions between different cell types
and between the cells and substrate. The goal of this work is to baseline the cellular
output from the bioprinter, using select cellular material conditions, and, using this
information, to determine the effect of defined spatial co-location of mammary epithelial
cells and mesenchymal stem cells.
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CHAPTER 2
INTRODUCTION
With the rising need for tissue models that may be effectively used for drug
testing or study of a disease process, much focus has been placed on developing threedimensional test systems that more accurately represent the in vivo environment and
provide data that can be more readily extrapolated to the human body. These test systems
possess the added advantage of reducing the use of animal models and obtaining more
information, thereby reducing the time and cost of moving ideas to the clinic [4]. Several
fabrication methodologies are available in developing these test systems, including inkjet
printing [40]. Inkjet printing has been proven to be only moderately successful in printing
cells, additionally, it was not intended for biological applications and hence the process
needs substantial refinement [60]. One advantage to inkjet printing is the ability to print
cells in specific patterns; however, it is yet to be established if a pattern contains a
uniform number of cells. While analyzing the differences between printed samples
subjected to various biological environments or samples printed on different biomaterial
substrates, it is necessary to be able to print a known number of cells in a defined,
repeatable configuration. The cell output from the cartridge must be standardized before
conducting any printing experiments; hence, this study assessed the effect of time and
initial cell concentration on the ability to print a uniform number of cells.
The bio-inks used in inkjet printing are limited by properties such as their density,
viscosity and surface tension. These properties influence the resolution of the ink droplet
19

formed and are hence vital to the printing process [72]. Chitosan, being biocompatible
and biodegradable and also amenable to chemical modification, has been used in adipose
tissue engineering [7]. Chitosan solutions possess very high viscosities; hence, to render
chitosan solutions suitable for printing applications, it is necessary to reduce the
polymeric chain length to reduce the solution viscosity. This degradation of chitosan can
be carried out through enzymatic, chemical or sonochemical means [73].
Though effective in reducing chain length, chemical degradation of chitosan
through acid hydrolysis results in low yields, formation of toxic byproducts and structural
modifications [74, 75]. Enzymatic degradation of chitosan is very expensive, as bulk
quantities of the enzyme are needed [76]. High intensity ultrasound has proven to be an
effective means of chitosan degradation. Ultrasound waves, when applied to a polymer
solution, result in the rapid formation and collapse of cavities which create conditions of
high pressure and shear, leading to depolymerization and considerable reduction in chain
length [77]. Ultrasonic degradation is inexpensive and does not produce any adverse by
products; hence this study included this method of degradation to create a chitosan based
bio-ink which could be printed to create a three-dimensional test system [78].
A breast tissue system allows one to obtain an enormous amount of information
regarding interactions of different cell types such as adipocytes, epithelial cells, and
fibroblasts, both with each other and with the microenvironment. The complex
relationship between mammary epithelial cells and adipose cells can provide clues
regarding the causes and progression of breast cancer [79]. The purpose of this work was
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to assess cellular output consistencies, and then to analyze the interactions between
mammary epithelial cells and adipogenic stromal stem-like cells, on both chitosan and
collagen substrates, using inkjet printing. Specifically, the study addresses whether the
differentiation of D1 cells is influenced by presence or absence of the NMuMGs and if
the particular spatial co-location of the two cell types has an effect on cellular behavior.
MATERIALS AND METHODS
Bioprinter cellular output consistency studies
Cell culture
D1 and NMuMG cell lines (American Type Culture Collection (ATCC),
Manassas, VA) were cultured in accordance with the distributor‟s protocol. D1 cells are
murine bone marrow stromal cells which can be maintained undifferentiated in culture
but possess the potential to differentiate into chondrocytes, osteocytes, and adipocytes,
based on the culture environment. NMuMG cells are epithelial cells derived from the
murine mammary gland.
D1s were maintained in Dulbecco‟s Modified Eagle‟s Medium (DMEM) (ATCC)
containing 4mM L-glutamine, 1.5g/L sodium bicarbonate, and 4.5g/L glucose. Every
500mL of medium was supplemented with 50mL fetal bovine serum (FBS) (ATCC),
5mL of antibiotic/antimycotic (AA) (Invitrogen, Eugene, Oregon) and 1mL of fungizone
(Invitrogen). NMuMGs were maintained in DMEM and every 500mL was supplemented
with 1µL/mL of bovine insulin (Sigma Aldrich, St. Louis, MO), 50mL FBS, 5mL AA,
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and 1mL fungizone. The cells were cultured at 37°C and 5% CO 2 and the culture medium
was replaced every two days.
Preparation of bio-ink
Bio-ink refers to the fluid consisting of cells, biomaterial or both, that is printed in
specific patterns. The bio-ink consisted of a cell suspension at a specific concentration.
D1 cells were grown on cell culture flasks (150cm2 , Sigma Aldrich) in the presence of
15mL DMEM, until 100% confluency, following which the cells were trypsinized,
counted with a hemocytometer and resuspended in serum-free DMEM (sf-DMEM). Four
different cell concentrations were chosen; 8, 12, 16 and 20 million cells/mL. The cells
were suspended in sf-DMEM and were filtered using a 0.45µm filter membrane (BD
Biosciences, Durham, NC) to eliminate any large cell aggregates which could clog the
cartridge nozzles. A volume of 1.06mM of ethylene diamine tetraacetic acid/ Hanks
Buffered Saline Solution (EDTA/HBSS) (Sigma Aldrich) was prepared by mixing
26.5µL of EDTA with 12.5mL of Hanks Buffered Saline Solution without Ca 2+ and
Mg2+. Prior to printing, 150µL of the cell concentrations were mixed with 150µL of
1.06mM of EDTA/HBSS, resulting in bio-inks containing cell concentrations of 4, 6, 8,
and 10 million cells suspended in 50% DMEM and 50% HBSS with an EDTA
concentration of 0.53mM.
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Printing
An HP 340 printer was modified by disabling the paper feed sensor and altering
the setup to accommodate glass slides. The cartridges used for printing were the HewlettPackard HP26 cartridges, which were cleaned using an in-house cleaning protocol. The
cartridges were first emptied of their ink and rinsed well with distilled water. They were
soaked in a rust and stain remover (Weiman Products, LLC,Gurnee, IL) and distilled
water, mixed in a 1:1 volume ratio, for 15 minutes after which the cartridges were rinsed
well with distilled water and soaked for 15 minutes in an instrument lubricant (Weiman
Products, LLC,Gurnee, IL) and distilled water in a 1:6 volume ratio, then ultrasonicated
using Branson 1510 ultrasonic cleaner (Branson Untrasonics Corporation, Danbury, CT)
for 5 minutes. Sonication was carried out to remove any residual material from the
nozzles. After sonication, 70% ethanol was passed through the nozzles for 5-10 seconds
using the house vacuum, after which the cartridges were air dried.
Clean microscopic glass slides (Fisherbrand, Fisher Scientific, Fair Lawn, NJ)
were used as printing substrates. A row of evenly spaced 10 dots was created using
Adobe Photoshop 7.0, where one pixel in the bitmap image corresponded to one drop
dispensed from the nozzle. A volume of 150 µL of the bio-ink was pipetted into a clean,
sterile cartridge. Once the bio-ink was pipetted into the cartridge, the pattern was printed
once every 3 minutes for a period of 15 minutes. This procedure was repeated for every
cell concentration. Once printed, the slides were imaged at 100X magnification using an
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inverted microscope (Carl Zeiss, Thronwood, NY, USA) and Image-Pro (Media
Cybernetics, Bethesda, MA) software.

Figure 2.1 Modified HP 340 printer (A), HP 26 cartridge (B).
10 seconds

15 minutes

Figure 2.2 Dot pattern for printing experiment.
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Image processing using MATLAB
An automated cell counting program was written in MATLAB to count the
number of cells per drop and the number of drops in the images. The images were resized
to 640x480 pixels, using Irfanview 4.25 graphic viewer (freeware), and then sorted into
different folders based on the respective cellular concentration of the bio-ink. MATLAB
7.8.0 (MathWorks) was used on a 1.83 Genuine Intel CPU with 512 MB RAM (Intel
Corporation, Santa Clara, CA). The images were analyzed separately to determine the
number of cells present in an image and the number of drops per image. Subsequently, all
of the images were converted to black and white using the automatic thresholding feature
in MATLAB. Following this step, using the MATLAB function termed „bwlabel‟, the
images were divided into regions and every region was analyzed for properties such as
area, eccentricity, and centroid. An area threshold of 20 pixels was determined and
regions that were larger than that area were considered to be cells. The number of drops
in an image was determined using edge detection. The images were converted to a
grayscale and Laplacian and gradient types of edge detection were applied to the images.
Since the intensity of a cell varies from that of the corresponding drop, the distinction
was maintained post edge detection. These images were again divided into regions and
the properties were determined. Thresholds were set and the number of drops was
counted. The centroid of the cell determined to which drop the cell belonged. If the
centroid of the cell was present within the bounding box of the drop (where the bounding
box locates the top most, bottom most, right most and left most points), the centroid was
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assigned to that drop and labeled. The output contained a list with the names of the
images and the corresponding number of cells per drop and number of drops.
Preparation of chitosan based bio-ink
Chitosan degradation
Chitosan (Fisher Scientific) with a molecular weight of 100,000-300,00Da was
used to prepare a 1% solution by adding 0.5g of chitosan to 50mL of 2% acetic acid and
stirring for a minimum of 4 hours at room temperature. The light brown coloration
obtained was indicative of the complete solubilization of chitosan.. Ultrasound
degradation was used to degrade the 1% chitosan solution. Specifically, 50mL of 1%
chitosan solution was placed in Branson 1510 ultrasound cleaner (Branson Untrasonics
Corporation) and was subjected to ultrasound for 2 hours at room temperature.
Molecular weight determination
Post degradation, the molecular weight of the solution was measured using gel
permeation chromatography. To measure the molecular weight, the degraded chitosan
was obtained in powder form. A volume of 10mL of the degraded chitosan was
precipitated by adding of 1N sodium hydroxide to the degraded chitosan solution under
constant stirring. The pH of the solution was measured at regular intervals using
Whatman pH indicator strips (VWR, West Chester, PA) until a pH of 9-10 was achieved.
Subsequently, the mixture was centrifuged at 5000rpm for 10 minutes at 25°C, the
supernatant removed, and the pellet was resuspended in 10mL of distilled water and
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centrifuged again at 5000rpm for 10 minutes at 25°C. This process was repeated twice to
completely remove any trace of sodium hydroxide from the pellet. The contents were
transferred to a vial, then stored at -80°C for 2 hours and subsequently freeze dried at
100mtorr using a Labconco benchtop lyophilizer ( Thermo Fisher Scientific, Inc.,
Waltham, MA) for at least 24 hours. The molecular weight of two samples were tested;
the first sample was degraded using ultrasound and the degraded solution was stored at
4°C for 2 months, after which the chitosan molecules were precipitated out using the
procedure described. The second sample was prepared by degrading chitosan solution
and precipitating the chitosan immediately. Gel permeation chromatography (GPC) was
conducted on the lyophilized chitosan powder using a Waters Breeze 1525 binary pump
and the Breeze HPLC software (Waters Corporation, Milford, MA). A Waters 2414
refractive index (RI) detector and a Waters Ultrahydrogel 250 column were employed.
The mobile phase was comprised of 0.33M acetic acid/0.2M sodium acetate. The
injection volume used in the column was 70 µL, the flow rate was 1mL/min and the
temperature of the columns was maintained at 25 degrees.
Cellular interaction studies
Slide preparation
Clean and sterile polystyrene cell culture slides (Nalge Nunc Inc, Rochester, NY)
were used in these studies. High purity silicone rubber film (McMaster-Carr, Atlanta,
GA) of 0.04” thickness and 55A durometer rating was used to create the masks. The
masks were cut out in the dimensions specified in Figure 2.3. The upper and lower masks
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were cut out and glued together using DAP household adhesive (RPM International,
Medina, Ohio). The silicone masks were then glued to the polystyrene slides using DAP
adhesive to prevent leakage of medium during the course of the experiment. After gluing
the masks, the slides were placed in a sterile hood and subjected to ultraviolet (UV) for 2
hours.

Figure 2.3 Image of upper and lower silicone masks.

Chitosan/gelatin gelation
Masses in the amount of 3g of chitosan powder and 3g of Bovine skin gelatin 6
(Sigma Aldrich) were sterilized using a Tuttnauer tabletop autoclave (Thermo Fisher
Scientific) at 121°C for 20 minutes. Chitosan and gelatin powder were slowly added to
50mL of 2% acetic acid solution under constant stirring and heat to form a 3%
chitosan/gelatin solution. A volume of 75 µL of the chitosan/gelatin solution was pipetted
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into the wells and placed in sterile petri dishes. The petri dishes were maintained at 4°C
for 30 minutes to allow gelation. The slides were then soaked with 1 mL 1N sodium
hydroxide solution and washed well with sterile distilled water to remove traces of
sodium hydroxide and to neutralize the gels. The gels were then soaked in 1mL of 1:1
ratio of FBS: DMEM for a minimum of 1 hour until further use.
Collagen gelation
Rat tail collagen, Type 1 (BD Biosciences,) was used to make collagen gels.
Polystyrene slides with attached silicone masks were used as the substrate for the gel. A
concentration of 2 mg/mL of collagen was prepared according to the following
composition:
1.028mL pure collagen solution
200µL 10X Dulbecco‟s phosphate buffered saline (PBS) (Fisher Scientific)
23µL 1N sodium hydroxide (NaOH) (MP Biomedicals, Solon, OH)
749µL sterile distilled water
A volume of 75µL of the above collagen solution was pipetted onto the
polystyrene slide, taking care to ensure that the solution touched the sides of the silicone
masks. The slides were placed in sterile petri dishes and were incubated for a minimum
of 1 hour at 37°C and 5% CO2. The collagen gels were soaked doused with 1mL of
sterile distilled water for 1 hour at room temperature. The water was then aspirated and
the gels were incubated with a 1:1 ratio of FBS: DMEM for a minimum of 1 hour.
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Preparation of bio-ink
D1 cells and NMuMG cells were trypsinized from cell culture flasks and counted.
Based on previous in-house experiments, 8 million cells/mL was deemed to be a suitable
cell concentration for printing experiments. A concentration of 16 million cells/mL of
each cell type was tagged with fluorescent dye prior to printing. D1 cells were tagged
with 40µM CFSE green dye (Invitrogen, Eugene, Oregon) and the NMuMG cells were
tagged with Hoechst dye 33342, trihydrochloride, trihydrate (Invitrogen).
The D1 cells were incubated for 15 minutes in 2mL of phosphate buffered saline
with the appropriate dye concentration. After incubation, the contents were centrifuged
for 5 minutes at 1000 rpm and 25°C. The cell pellet was resuspended in 2mL of DMEM
and incubated for 30 minutes for complete attachment of the dye. The contents were
centrifuged again at 1000 rpm for 5 minutes at 25°C and the cell pellet was resuspended
in 1mL serum-free DMEM.
The NMuMG cells were incubated for 30 minutes at 37°C and 5%CO 2 in 2mL of
DMEM containing 5µg/mL of the Hoechst dye. At the end of incubation, the cells were
centrifuged at 1000rpm for 5 minutes at 25°C and the cell pellet was resuspended in 1mL
of serum-free DMEM. Post-tagging, the bio-ink was prepared as described earlier; the
cells were filtered using the 0.45µm filter membrane and mixed with 1.06mM
EDTA/HBSS, resulting in a final cell concentration of 8 million cells/mL suspended in
50% DMEM, 50% HBSS and an EDTA concentration of 0.53mM.
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Printing
Three different patterns were designed: a pattern where only D1 cells were
printed, a pattern where both the D1 cells and NMuMGs were printed at a defined
distance apart, and a pattern where D1s and NMuMGs were printed in close proximity
(Figure 2.4). The printing patterns were designed using Adobe Photoshop 7.0; each
measured 200 pixels × 15 pixels.

Figure 2.4 Schematic of the printed samples. Blue lines represent D1 cells and green
lines represents NMuMG cells. (A) Slide with D1 cells only, (B) slide with D1 cells and
NMuMG cells printed in close proximity, (C) slide with D1 cells and NMuMG cells
printed at a distance of 2cm apart.

Three substrates were chosen for the study: collagen gels, chitosan/gelatin gels
and polystyrene slides. The samples were divided into two groups; one group comprised
printed samples and the second group comprised pipetted samples. For every slide
printed, three cartridges were required; one cartridge contained D1 cells, another
contained NMuMGs and the third cartridge was used to print serum-free medium on the
printed cells. The cartridges were cleaned and sterilized as per the cleaning protocol
described earlier and 100µL of the fluorescent tagged cells was pipetted into the wells of
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the cartridges. The HP 340 inkjet printer was used for the printing. All of the substrates
were treated to 1mL of 50% FBS and 50% DMEM for a minimum of 1 hour prior to
printing. Once the samples were printed, they were placed in sterile plastic 150mm petri
dishes (VWR) and incubated at 37°C and 5% CO 2 until the post-printing treatment.
The printed samples were compared to samples where the cells were pipetted onto
the substrates. The pipetted group contained two samples; one sample contained D1 cells
and the second sample contained a mixture of D1 cells and NMuMG cells. The results
from the cell settling experiments determined the number of cells printed in each sample
and the same number of cells was used in the pipetted group. The equivalent number of
cells was suspended in 50µL of NMuMG medium (DMEM supplemented with 1µL/mL
insulin) and was pipetted in the wells of every sample. The samples were then placed in
sterile petri dishes and incubated at 37°C and 5% CO 2 until the post-printing treatment.
The polystyrene slides served as the control. The experimental layout is explained in
Table 2.1.
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Table 2.1 Experimental layout
GROUP

Number

Substrate

GROUP

Collagen (C)

SLIDE 1: D1s printed

1

Slide 2: D1s and NMuMGs
printed in close proximity

PRINTED GROUP
(Pr group)

SLIDE 3:D1s and NMuMGs
printed 2cm apart
GROUP

Chitosan/gelatin

2

(CG)

SLIDE 4: D1s printed
Slide 5: D1s and NMuMGs
printed in close proximity
SLIDE 6: D1s and NMuMGs
printed 2cm apart

GROUP

Polystyrene

3

(PS)

slide SLIDE 7: D1s printed
Slide 8: D1s and NMuMGs
printed in close proximity
SLIDE 9: D1s and NMuMGs
printed 2cm apart
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GROUP
Pipetted group (Pp

Collagen (C)

SLIDE 10: D1s pipetted

4

SLIDE 11: D1 and NMuMGs

group)

pipetted
GROUP

Chitosan/gelatin

5

(CG)

SLIDE 12: D1s pipetted
SLIDE 13: D1 and NMuMGs
pipetted

GROUP

Polystyrene

6

(PS)

slide SLIDE 14: D1s pipetted
SLIDE 15: D1 and NMuMGs
pipetted

Control

GROUP

SLIDE 16: Collagen control

7

slide
SLIDE 17: Chitosan control
slide

Post printing treatment
The post printing sample treatment was developed based on previous in-house
experiments. Once cells were printed onto the substrates, a separate cartridge was used to
print a single pass of serum-free media (pattern used for printing is the same used in
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printing cells). The samples were incubated for 1 hour at 37°C and 5% CO 2, following
which the cells were subjected to a nebulizer treatment. An Omron NEC-25 CompAir
XLT desktop nebulizer (Omron Healthcare, Inc. Bannockburn, Illinois) was used. The
medicine cup of the nebulizer was filled with approximately 5mL of DMEM
supplemented with insulin, and the mist was created through a tube attached to the
medicine cup. The tube was held approximately 5cm above the sample and every sample
was treated to a mist of media for approximately 30 seconds. The samples were again
placed in the incubator and, 2 hours after printing, 750µL of medium containing insulin
was pipetted on each sample. The pipetted samples were incubated for 30 minutes,
following which 750 µL of medium containing insulin was pipetted onto each sample.
The medium was changed once every 2 days for 10 days, when the cells were fully
confluent. The confluent cells were then treated with medium containing an adipogenic
cocktail for 6 days until the appearance of lipid moieties.
Table 2.2 Post printing treatment of the printed samples
PRINTED GROUP
SUBSTRATE

0 min

30 min

COLLAGEN

Printed

Mist of

750µL of

serum-free

medium for 30

medium with

DMEM

seconds

insulin
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60 min

90 min

CHITOSAN

POLYSTYRENE

Printed

Mist of

750µL of

serum-free

medium for 30

medium with

DMEM

seconds

insulin

50µL of

50µL of

750µL of

medium

medium

medium with

with insulin

with insulin

insulin

50µL of

50µL of

750µL of

medium

medium

medium with

with insulin

with insulin

insulin

50µL of

50µL of

750µL of media

medium

media with

with insulin

with insulin

insulin

50µL of

50µL of

750µL of

medium

medium

medium with

with insulin

with insulin

insulin

PIPETTED GROUP
COLLAGEN

CHITOSAN

POLYSTYRENE
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Cellular Characterization
Lipid analysis
The medium was aspirated from the slides and the samples were washed with
phosphate buffered saline. Using 1mL of 10% formalin, the cells were fixed for 4 hours.
The fixative was aspirated and the samples were washed with distilled water. A volume
of 500µL of Oil Red O working solution was added to each of the samples and incubated
for 20 minutes. The samples were then washed three times with distilled water. Images
were taken using an inverted microscope at 320X magnification. Post imaging, 500µL of
isopropanol was added to each sample and the samples were incubated at room
temperature for 15 minutes to extract the stain from the lipid produced by the cells.
Approximately 100µL of the solution was pipetted into the wells of a 96-well plate and
the absorbance was measured at a wavelength of 530nm using a microplate reader. Every
sample was read in triplicates. The average of the three values for each sample was taken
and plotted. The Oil Red O stock solution was prepared by dissolving 0.5g Oil Red O in
100mL of isopropanol and filtered using a 0.22µm filter membrane. The Oil Red O
working solution was prepared by mixing the Oil Red O stock solution with distilled
water in a ratio of 3:2. The solution was then filtered using a 0.22µm filter membrane.
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Reverse Transcriptase Polymerase Chain Reaction was performed to determine
the expression of genes specific to the differentiation of D1 cells. RNA was isolated from
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each sample, the purity of the sample was tested and PCR was conducted using the
primers designed for the specific genes of interest.
RNA isolation
RNA was isolated from the samples using the RNeasy Mini Kit (Qiagen,
Valencia, CA). The medium was aspirated from the samples and the cells were washed
with PBS. After washing all the samples with PBS, the collagen gel samples were
digested with 4mg/mL collagenase (172units/mg) (Sigma Aldrich) in 2mL of HBSS for
15 minutes. The chitosan/gelatin gel was digested using 4mg/mL collagenase and 2 units
chitosanase (Sigma Aldrich) in 2mL of HBSS for 30 minutes. The polystyrene samples
were treated to 1mL trypsin for 5 minutes at 37°C after which all of the cells were
scraped off the slide. All of the samples were centrifuged at 1000rpm for 5 minutes at
25°C. The supernatant was aspirated and the pellet was subjected to RNA extraction.
RNA extraction was then carried out by directly lysing the cell membrane. The
contents were incubated in 350µL of the Buffer RLT (provided by the Qiagen kit) for
about 20 minutes. The samples were homogenized well by passing the lysate through a
20 gauge needle about 10-15 times. An equal volume of 70% ethanol prepared with
RNase-free water, was added to the homogenized samples and mixed well by pipetting
several times. The samples were then transferred to QIAshredder spin columns which
were inserted in 2mL collection tubes. The tubes were then centrifuged at 10,000 rpm for
15 seconds. The flow through in the collection tube was discarded. 700µL of the Buffer
RW1 was added to the spin column and the tubes were centrifuged at 10,000 rpm for 15s.
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The flow through was again discarded from the collection tube. 500µL of the Buffer RPE
was added to the spin columns and the tubes were again centrifuged at 10,000rpm for
15s. The flow through was discarded and the process was repeated again. The spin
column was then placed in a fresh collection tube and 30µL of RNase-free water was
added to the spin column. The tubes were centrifuged at 10,000 rpm for 1 minute to elute
the RNA into a 1.5mL collection tube.
A combination of the RNeasy Mini kit and TRIzol® reagent (Invitrogen, Eugene,
Oregon) was used to extract RNA from the chitosan/gelatin samples. The chitosan/gelatin
gel samples were incubated in to 500µL of TRIzol reagent for 15 minutes at room
temperature. About 200µL of chloroform (Sigma Aldrich) was added to the samples and
the contents were thoroughly mixed by vortexing for 30 seconds. The samples were then
incubated for 5 minutes at room temperature, after which they were centrifuged at
5000rpm for 15 minutes at 4°C. The samples were then subjected to RNA extraction
using the RNeasy mini kit. All of the samples were stored at -80°C until further use.
RNA quantification
Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.) was used to determine the
concentration and purity of the RNA samples. RNA 6000 Nano Assay Kit (Agilent
Technologies, Inc.) was used to prepare the samples for quantification. The RNA 6000
Nano gel matrix was prepared by centrifuging 550µL of the matrix at 4,000 rpm in a
Thermo Scientific Sorvall microcentrifuge (Thermo Fisher Scientific) for 10 minutes
using a spin column and was subsequently aliquoted. A volume of 65µL of the gel
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matrix was mixed with 1µL of the RNA 6000 Nano dye and thoroughly mixed by
vortexing. The mixture was then centrifuged for 10 minutes at 13000 rpm. A volume of
9µL of the centrifuged gel-dye matrix was then loaded into the well denoted “G” on the
RNA 6000 Nano LabChip (Caliper Technologies Corp, Mountain View, CA). The chip
was then pressurized for exactly 30 seconds using the Chip Priming Station (Agilent
Technologies, Inc.). The other two wells denoted “G” were each loaded with 9µL of the
gel-dye mixture. A volume of 5µL of the RNA 6000 Nano Marker was loaded into all the
remaining wells (sample and ladder wells). The RNA 6000 ladder (Ambion, Inc. Austin,
TX) was heated to 70°C for 2 minutes and aliquoted. A volume of 1µL of the ladder was
loaded into the well denoted ladder. The RNA samples were thawed on ice and 1µL of
the samples was loaded into each of the sample wells. A volume of 1µL of the RNA 6000
Nano marker was loaded into any empty sample wells. The chip was vortexed for 1
minute at 2400rpm. The electrodes of the Agilent 2100 Bioanalyzer were thoroughly
cleaned of any residual RNase by placing them in RNase away (Ambion, Austin,TX) for
1 minute. The electrodes were then washed with RNase-free water. The chip was placed
in the Bioanalyzer and the 2100 Expert Software (Agilent Technologies Inc.) was used to
determine the concentration of the RNA and its purity. The 2100 Expert software was
used to determine the 28s/18s ratio and also to determine the RNA integrity number
(RIN). Samples that had a RIN of above 9.5 were used and the remaining samples were
discarded.
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Primers for RT-PCR
The genes of interest were mouse CCAAT/enhancer-binding protein alpha
(C/EBP-α), mouse peroxisome activator receptor-gamma (PPAR-γ), and mouse
adipocyte-specific fatty acid-binding protein-2 (aP-2) and mouse glyceraldehyde-3phosphate dehydrogenase (GAPDH), where GAPDH served as the housekeeping gene.
The primers were designed and used in-house for previous studies; the sequences are
listed below. The designed primers were ordered (Integrated DNA Technologies (IDT),
Coralville, Iowa) and received in a lyophilized powder form which was resuspended in
the appropriate volume of RNase-free water to a stock concentration of 100µM and
stored at -20°C until use.
Table 2.3 Primer Sequences for Target Genes
Sense primer (5‟-3‟)

Antisense primer (3‟-5‟)

C/EBP-α

CTGGAAGTGGGTGACTTAGAGG

GAGTGGGGAGCATAGTGCTAG

PPAR-γ

ACC ACT CCC ATG CCT TTG AC

AAC CAT CGG GTC AGC TCG

Target
gene

TG
aP-2

ATGTGTGATGCCTTTGTGGGA

TGCCCTTTCATAAACTCTTGT

GAPDH

GAACGGATTTGGCCGTATTG

CGTTGAATTTGCCGTGAGTG
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Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
QuantiTect SYBR Green RT-PCR (Qiagen, Valencia, CA) was used to measure
the level of gene expression. As per the manufacturer‟s protocol, the QuantiTect SYBR
Green RT-PCR master mix, QuantiTect Reverse Transcriptase mix, template RNA,
primers for the sense and antisense strand and RNase-free water were mixed to make a
total reaction volume of 25µL in 0.2mL PCR reaction tubes (Fisher Scientific). A volume
of 12.5µL of the master mix was combined with 0.25µL of the RT-mix. A volume of 1µL
of the forward and reverse strand primers were added to the mixture. The concentration
of template RNA used per sample was 10ng. The appropriate volume of template RNA
was added to the mixture and the balance of 25µL reached using RNase-free water. A no
template control (NTC) sample was prepared with all of the above with the exception of
the template RNA. Yet another control was the minus reverse transcriptase control (RTC) which was prepared without the RT-PCR enzyme mix. For both the controls, the
balance of the volume was reached using RNase-free water.
The Rotor-Gene thermo cycler (Corbette Life Science, Sydney, Australia) was
used for the reaction. The thermo cycler conditions included a reverse transcription step
to create complimentary DNA from the template RNA, an initial PCR activation step, the
denaturation of the double stranded DNA, annealing of the primers to the strands and
extension of the samples. The samples were amplified for 40 cycles. The results were
analyzed using the delta delta Ct method.
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Table 2.4 Thermocycler Conditions
Steps

Time

Temperature

Reverse transcription

10min

50°C

PCR activation step

5min

95°C

Denaturation

10sec

95°C

Combined annealing and extension

30sec

60°C

Calculation of relative gene expression
The gene expression of the samples was calculated using the delta delta Ct
method of data analysis. This method makes the assumption that the amplification
efficiency of all genes is equal and approximately 1. The relative expression of the
sample groups (cells on collagen and chitosan/gelatin gel) is calculated in reference to the
control groups (polystyrene surfaces) using the following formula.

ΔΔCt=ΔCt(sample)-ΔCt(control)
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RESULTS
Cells/Drop Analysis
The cellular output consistency studies showed an increase in the D1 output with
increase in cell concentration; there was an increase up to cell concentration of 8 million
cells/mL and then a decrease in cell output for concentration of 10 million cells/mL. It
was also seen that, for each cell concentration, with increase in time the number of cells
per printer “pass” increased. It was also seen that in every pass printed, irrespective of the
cell concentration and time, the first drop contained a higher number of cells in
comparison to the other drops. The maximum cell output was obtained with a cell
concentration of 8 million cells/mL and an average of one cell per drop at Time 0.
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Figure 2.5 D1 output varies with drop and print pass.
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Figure 2.6 Average number of D1s per drop is highest at 8 million cell/mL.

Satellite drops

A

B

Figure 2.7 Printed cells (A) shows the printed drops (B) shows the presence of smaller
drops which are satellite drops. Images taken at 100X total magnification.

When the same experiment was repeated using NMuMGs, similar results were
observed, with an increase in cell concentration up to 8 million cells/mL followed by a
subsequent decrease in the cell number for 10 million cells/mL. Printing the NMuMGs
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resulted in a higher cell output than when printing the D1s. At a cell concentration of 8
million cells/mL, there was an average of two cells per drop at Time 0.
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Figure 2.8 NMuMG output varies with drop and print pass.
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Figure 2.9 Average number of NMuMGs per drop is highest at 8 million cell/mL.

Gel Permeation Chromatography
The chromatograms obtained for the chitosan samples indicated little or no
difference in the molecular weight between the two chitosan solutions. The first peak in
the chromatogram corresponded to that of the sample and the other two peaks
corresponded to the mobile phase. The retention time of the samples was lower than that
of the standards and so it was not possible to determine the exact molecular weight.
However, using the equation generated from the standards, the approximate molecular
weight was found to be 90,000Da.
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Figure 2.10 Blue plot denotes solution A and red plot denotes solution B; the molecular
weights are almost identical.

GPC Standard curve
Molecular weight in Da

25000
y = 1250x2 - 750x + 3750

20000
15000
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10000

Poly.
(Standards)

5000
0
11.971

10.974

10.514

9.927

Retention time in minutes

Figure 2.11 The standards indicate a nonlinear relationship that may be used to
approximate the molecular weight of the two solutions.
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Printing
The cellular output data indicated that for a cell concentration of 8 million
cells/mL, one D1 cell was printed in every drop and two NMuMGs cells were printed in
every drop. The pattern consisted of 3000 pixels, with 15 passes of the D1s and 8 passes
of the NMuMGs, resulting in 45,000 cells. The same number of cells was seeded in the
pipetted groups.

A

B
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D

E

F
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H
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Figure 2.12 Images show the maximum D1 cell growth on polystyrene surface (A) Day 1
image of cells on collagen gel (B) Day 1 image of cells on chitosan/gelatin gel (C) Day 1
image of cells on polystyrene surface (D) Day 4 image of cells on collagen gel (E) Day 4
image of cells on chitosan/gelatin gel (F) Day 4 image of cells on polystyrene surface (G)
Day 10 image of cells on collagen gel (H) Day 10 image of cells on chitosan/gelatin gel
(I) Day 10 image of cells on polystyrene surface. Day 1 images (A,B and C) were taken
at 40X total magnification and the remaining images taken at 100X total magnification.

The difference in the proliferation rate likely caused by the different surfaces can
be seen from the images. The Day 1 images show a higher number of cells on the
polystyrene surface. By Day 4, the cells on polystyrene surfaces were around 75-80%
confluent had started spreading beyond the masks, whereas the cells on the
chitosan/gelatin gels were less than 50% confluent. By Day 4, the collagen gels had
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reached around 50-60% confluency. The collagen gels achieved 100% confluency by
Day 10 whereas on the chitosan/gelatin gels, the cells had not reached 100% confluency.
Lipid Analysis
The Oil-Red-O analysis showed the presence of lipid moieties in all samples after
6 days.
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F
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Figure 2.13 D1 cell differentiation occurred on all the substrates for the printed and
pipetted samples as seen by the formation of lipid moities (A) is Pr group-C-D1 (B) is Pr
Group-C-D1/NMu near (C) is Pr Group-C-D1/NMu far (D) is Pr Group-CG-D1 (E) is Pr
Group-/G-D1/NMu near (F) is Pr Group-CG-D1/NMu far (G) is Pr Group-PS-D1 (H) is
Pr Group-PS-D1/NMu near (I) is Pr Group-PS-D1/NMu far (J) is Pp Group-C-D1 (K) is
Pp Group-C-D1/NMu (L) is Pp Group-CG-D1 (M) is Pp Group-CG-D1/NMu (N) is Pp
Group-PS-D1 and (O) is Pp Group-PS-D1/NMu. All images were taken at 200X
magnification.

Table 2.5 Oil-Red-O absorbance data
Sample

1st reading 2nd reading 3rd reading

Pr Group-C-D1

0.813

0.888

0.861

Pr Group-C-D1/NMuMG near

0.829

0.832

0.967

Pr Group-C-D1/NMuMG far

0.793

0.826

0.862

Pr Group-CG-D1

0.731

0.782

0.791

Pr Group-CG-D1/NMuMG near

0.955

0.909

1.04

Pr Group-CG-D1/NMuMG far

0.855

0.765

0.744

Pr Group-PS-D1

0.626

0.7

0.816

Pr Group-PS-D1/NMuMG near

0.666

0.643

0.659
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Pr Group-PS-D1/NMuMG far

0.796

0.851

0.96

Pp Group-C-D1

0.714

0.681

0.699

Pp Group-C-D1/NMuMG

0.931

0.904

0.793

Pp Group-CG-D1

0.727

0.682

0.751

Pp Group-CG-D1/NMuMG

0.895

0.907

0.862

Pp Group-PS-D1

0.796

0.706

Pp Group-PS-D1/NMuMG

0.781

0.804

0.767

Lipid analysis

Absorbance at 530nm

1.2
1
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0.6
chitosan

0.4
0.2

polystyrene

0

Pr D1
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D1/NMuMG D1/NMuMG
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far

Pp D1

Pp
D1/NMuMG

Samples

Figure 2.14 Oil-Red-O absorbance data does not reveal significant differences.
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As shown in Figure 2.14., the absorbance value for the D1 cells that was pipetted
and grown on all the three surfaces in the presence of NMuMG cells was slightly higher
than that of D1 cells grown alone. On chitosan/gelatin surfaces, higher absorbance was
seen for the sample where the D1s and NMuMGs were printed near. On the polystyrene
surfaces, the highest average absorbance was observed in the sample where D1 and
NMuMGs were printed at a distance; on the collagen surfaces, D1 cells and NMuMGs
printed in close proximity and a distance apart resulted in the highest average absorbance.
RT-PCR
RNA Concentration and Purity
Analysis of RNA extracted from the cells seeded on chitosan and collagen gels did not
result in an RIN number and confirmed very low concentrations. However, these samples
were also considered for PCR. The samples on the polystyrene slides gave an RIN of
higher than 8 and were considered for further analysis. The concentration of RNA in the
different samples is seen in Table 2.6.
Table 2.6 RNA quantification. The printed and the pipetted samples showed poor RNA
yield for all substrates
Sample

RNA Concentration (ng/µL)

Pr Group-C-D1

8

Pr Group-C-D1/NMuMG near

42

Pr Group-C-D1/NMuMG far

12

Pr Group-CG-D1

2

Pr Group-CG-D1/NMuMG near

3
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Pr Group-CG-D1/NMuMG far

4

Pr Group-PS-D1

5

Pr Group-PS-D1/NMuMG near

8

Pr Group-PS-D1/NMuMG far

5

Pp Group-C-D1

12

Pp Group-C-D1/NMuMG

32

Pp Group-CG-D1

3

Pp Group-CG-D1/NMuMG

6

Pp Group-PS-D1

6

Pp Group-PS-D1/NMuMG

6

PCR quantification
All of the samples were analyzed for the presence of various genes seen during
adipogenesis. The starting concentration for the PCR amplification was 10 nanograms.
After amplification, a threshold of 0.01 was set for all the samples and the cycle threshold
(Ct) values were calculated using the Rotor gene software.
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Table 2.7 Ct values of samples. The Ct values seen for the GAPDH gene differs
considerably between samples
Samples

Ct

for Ct for C/EBP Ct for PPAR- Ct
α

GAPDH

γ

for

aP2

Pr Group-C-D1

23.94

25.28

27.28

22.42

Pr

19.49

33.36

22.08

17.16

Pr Group-C-D1/NMuMG far

19.82

30.91

22

17.88

Pr Group-CG-D1

21.5

27.07

24.55

Pr

Group-CG-D1/NMuMG

19.04

33.84

23.14

18.42

Group-CG-D1/NMuMG

23.29

32.37

22.29

18.73

28.76

23.46

Group-C-D1/NMuMG

near

near
Pr
far
Pr Group-PS-D1

22.68

Pr

Group-PS-D1/NMuMG

19.07

31.92

23.35

19.18

Pr Group-PS-D1/NMuMG far

19.89

29

22.92

20.23

Pp Group-C-D1

22.84

31.94

23.96

23.38

Pp Group-C-D1/NMuMG

20.08

33.45

23.84

18.51

Pp Group-CG-D1

23.21

32.49

25.79

23.59

Pp Group-CG-D1/NMuMG

22.35

23.23

19.89

Pp Group-PS-D1

22.11

24.37

22.95

near

59

Pp Group-PS-D1/NMuMG

20.56

33.4

23.73

21.18

relative gene expression

7
6
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C/EBP-α

4
PPAR-γ

3
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Pr-C D Pr-C
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Pr-C Pr-CG Pr-CG Pr-CG Pp-C D Pp-C Pp-CG Pp-CG
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D/N D/N
D/N
D
D/N
far
near far

Collagen and chitosan/gelatin samples
Figure 2.15 Amplification data for the genes shows that the expression of aP-2 is higher
in the presence of NMuMGs for the printed and pipetted samples. D refers to D1 cells
and N refers to NMuMGs

From the gene expression data it can be seen that the gene expression of aP-2 is
higher in the presence of NMuMGs than when compared to samples that had only D1
cells for the printed and pipetted samples. The expression of C/EBP-α was almost zero in
all the samples except for the chitosan/gelatin gel sample with D1 cells printed and the
collagen gel sample with D1 and NMuMGs pipetted (case samples 4 and 11).. The gene
expression of PPAR-γ was highest on the chitosan/gelatin sample with D1 cells alone.
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The collagen gel samples also showed relatively high expression of PPAR-γ. The
samples that were printed and samples that were pipetted both showed an increase in aP-2
expression. The pipetted samples were marginally higher in aP-2 production than the
printed samples.
DISCUSSION
The purpose of this research was to determine the effect of time and initial cell
concentration on the ability to print a uniform number of cells from an inkjet bioprinter
and to compare cellular behavior in printed patterns with cellular behavior in pipetted
patterns. It is possible to print precisely reproducible patterns of cellular biomaterials, but
only if the number of cells deposited per drop is consistent. To use inkjet printing for the
development of cellular assays and tissue test systems, where tissue samples can be
accurately compared with one another, one must have confidence in the ejection of
consistent number of cells per drop from the inkjet printhead. This issue must be
addressed for inkjet printing to be a successful cell deposition tool.
The increase in cell number printed with increase in the initial cell concentration
was expected. Additionally, it was seen that a maximum cell number was observed with
cell concentration of 8 million cells/mL which was corroborated by studies by Parzel and
coworkers, which showed that a D1 cell concentration of 7.7 million cells/mL allows, on
average, the ejection of one cell per drop at time 0 [70, 80]. However, these observations
are only valid if printing is conducted immediately after the initial cell suspension is
loaded in the cartridge. Cell settling is observed with an increase in time between loading
and printing, which leads to a higher cell number per drop with increase in time. Hence
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there is a strong need for efficiency in the printing process as well as a means of
prohibiting cell settling in the cartridge.
It must be noted that the efficiency of printing is greatly influenced by the prior
wear and use of a cartridge. The number of times a cartridge has been previously used
affects its printing efficiency, which results in variability in the cell number printed. The
cleaning procedure used for the cartridges involved sonication for short periods of time
(10 minutes), which could cause an increase in the nozzle diameter, resulting in higher
number of cells per drop. Nagarajan and coworkers have shown that increasing the
sonication time causes erosion of the material [81]. It therefore makes sense to study the
effects of sonication on cartridges and to determine the number of times a cartridge can
be reused without any effect on its efficiency. Additionally, it will be important to
review alternate cleaning methods and to consider designing a custom-made cartridge of
more durable material.
The cell settling study shows that for a cell concentration of 8 million cells/mL,
there is an average of one cell per drop for D1s and two cells per drop for the NMuMGs.
The NMuMGs are larger and denser cells than the undifferentiated D1s [82], which likely
results in rapid settling of the NMuMGs and higher average cell/drop ejected as
compared to the D1s. This observation also indicates the need to perform a cell ejection
study as a function of time and concentration for every cell type printed.
In all of the passes printed, the first drop contained a considerably higher number
of cells than the other drops. The cell suspension is allowed to rest undisturbed for
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approximately 3 minutes pre-printing, during which time the cells likely settle, causing a
larger number to be ejected in the first drop. The same printhead nozzle was fired to print
all the drops in the pattern, resulting in higher cell number only in the first drop.
The vital part of inkjet printing is the physical properties of the ink, especially its
viscosity and surface tension. When a highly viscous solution is used as the ink, the
kinetic energy is dissipated and no drop is formed. At low viscosities, the velocity and
volume of the liquid ejected from the nozzle increases, forming a long tail behind the
drop. The surface tension of the liquid is responsible for the spherical shape of the drop
[72].
Figure 2.7 shows the presence of a number of satellite drops. When a drop is
formed, a minute volume of liquid connects the drop to the remaining solution. When this
connection is broken, the liquid thread forms satellite drops, as seen in the figure. Studies
by Dong and coworkers have shown that the formation of satellite drops can be reduced
by increasing the viscosity and reducing the surface tension of the liquid [83]. Meyer and
colleagues studied the effect of increasing concentration of polymer molecular weight on
the drop formation. Upon increasing the concentration of molecular weight of the
polymer, fewer satellite drops were observed until only one primary drop was ejected,
due to the merging of the satellite drops with the primary drop [84].
To determine if a particular solution is suitable for printing, Fromm formulated
the following equation, where We is the Weber number, Re is the Reynolds number, η is
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the viscosity of the liquid, ρ is the density of the liquid, γ is surface tension and α is the
nozzle diameter.

For a fluid to be printable, the Z value must be between 1 and 10, i.e. 1<Z<10. A
very viscous solution will have a large Z value, and the energy will be dissipated in the
fluid. In contrast, satellite drops will be produced from lower viscosity solutions with
lower Z values [85, 86].
The development of image processing algorithms in this study helped reduce the
time involved in processing. The first few drops were identified and counted manually;
the results from these preliminary counts were used to set the parameters for automated
counting. For example, a drop that was partially present along the margins of the image
was not considered in the count by the edge detection feature on the software. Also, the
size of the cells varied from image to image and this variation was standardized using the
manually counted drops.
Chitosan, though an excellent biomaterial for tissue engineering applications,
possesses high viscosities even at low polymer concentrations, rendering a unmodified
chitosan solution unsuitable for printing. To make the solution suitable for printing, it
was necessary to reduce the molecular chain lengths and thereby reduce the solution
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viscosity. Ultrasonic treatment results in an initial rapid depolymerization which
gradually slows down, resulting in a limiting final molecular weight [87]. Increasing the
time of degradation of the chitosan solution did not result in further reduction of
molecular weight. The degraded solution of chitosan could be printed; however, due to
unavailability of a viscometer of appropriate viscosity range; it was not possible to
measure the viscosity and the surface tension of the degraded solution [88].
The standard set used in the GPC measurements was a polyethylene glycol set,
which is commonly used in molecular weight measurement of chitosan. However, the
lack of availability of PEG standards having the molecular weight range of the samples,
only allowed an approximation of the chitosan molecular weight.

GPC separates

molecular chains based on their conformation rather than the molecular weight. Every
molecular chain has a specific conformation; hence it is optimal to use standards of the
same polymer for GPC measurements [89]. Polyethylene glycol has been shown to have
a random coil conformation in organic solvents and a helical conformation in aqueous
solvents. The conformation of chitosan varies from rod shaped to a semi flexible coil
depending on the solvent and the material properties. This difference in chain length and
conformation will cause the elution of the chitosan molecules at different times when
compared to PEG molecules [90] [89]. Studies by Wu and coworkers showed that lower
molecular weight values of ultrasound- degraded chitosan were more readily obtained by
GPC-MALLS analysis (Gel permeation chromatography coupled with a multi-angle laser
light scattering detector) [91].
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Polystyrene tissue culture slides were chosen to use as controls because tissue
culture treated polystyrene provides an adhesive surface for cells. Collagen, one of the
two experimental substrates, is a hydrophilic, natural material that possesses binding sites
that favor cell attachment. Chitosan, the second experimental material, is also naturally
derived and has been used in wound healing [92]. Gelatin, the denatured form of
collagen, was blended with chitosan to increase cell adhesion.
During the gelation of chitosan/gelatin gels, the gelatin present in the solution is
gelled first by reducing the temperature of the solution. The gelatin chains exist in a
random coil conformation at temperatures of around 40°C. However, when the
temperature is reduced, intra-chain hydrogen bonding between the denatured “collagenlike” chains takes place, resulting in triple helices [93]. Under acidic conditions, the
protonated amino groups on the chitosan backbone undergo electrostatic repulsion,
causing the material to remain in solution. When the pH of the solution is increased, the
electrostatic repulsion reduces forming intermolecular bonds and results in gelation [94].
This pH-induced gelation of chitosan occurs very rapidly and requires that all the
surfaces come in contact with the basic medium at the same time to allow uniform
gelation. When the basic solution is added after gelation, the gelatin forms a barrier and
the chitosan molecules slowly come in contact with the basic solution. This helps in
reducing the uneven surfaces formed when chitosan is gelled first.
The pretreatment of slides allowed serum and media proteins to adsorb to the
substrates and provide adhesion sites for the printed cells. Interestingly it was found that,
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for the cells to attach, this treatment must occur one hour before the printing process. A
24-hour treatment of these surfaces resulted in very poor attachment of the cells. This
poor attachment of cells could be as a result of the so-called Vroman effect, in which
proteins with higher mobility that first attach to the substrate can be displaced by proteins
that arrive later but which have higher affinity for the substrate. The competitive
adsorption of the serum proteins could result in non availability of the cell binding sites
essential for cell attachment. Cell adhesion is also influenced by the presence of proteins
such as fibronectin and laminin [95, 96]. Fibronectin has higher mobility and is adsorbed
faster to substrates. A study by Grinnell and coworkers showed that, at high serum
concentrations such as 10%, fibronectin initially adsorbs on the substrate surface;
however, with extended incubation time, other proteins present in the serum compete
with fibronectin for substrate adsorption, resulting in displacement of fibronectin [97].
The pretreatment cocktail used for this study contained more than 50% serum and was
incubated for 24 hours. This could have resulted in displacement of fibronectin and other
cell adhesion proteins, causing poor cell attachment.
The post-printing treatment was adapted from the work by Pepper and coworkers.
Cells require at least one hour for attachment to the substrate, and the nebulizer treatment
serves to keep the cells hydrated and viable during the attachment process. Pepper and
coworkers additionally suggested the use of a collagen overlay, which was not applied in
our studies because the collagen could hinder communication between the cells [98].
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Once the cells were printed and pipetted, they were allowed to proliferate in
growth medium for 10 days. Differentiation of D1 cells requires confluency. Differences
in the cell proliferation rate were observed on the different surfaces. Cells on the tissue
culture polystyrene surface and collagen surfaces achieved 100% confluency by 10 days
where as cells on the chitosan/gelatin surface did not (Figure 2.12). The presence of cell
adhesion sites, the surface topography, the mechanical strength, all play a role in cell
proliferation; differences in these parameters might have resulted in the differences in cell
proliferation rates, with polystyrene surfaces yielding the highest proliferation rate and
chitosan/gelatin surface yielding the lowest cell proliferation rate. The high volume of
medium used to suspend the pipetted cells likely prevented many of the cells from
remaining on the surface of the gels.

The lower absorbance values in polystyrene

samples with D1 and NMuMGs printed in close proximity was likely because of the
faster proliferation rate resulting in a cellular sheet and delamination from the surface.
During RNA extraction, some amount of the RNA is lost during sample
preparation and handling. When low cell numbers are used, the extraction of RNA from
chitosan gels results in poor yields. RNA has been shown to bind to cationic chitosan,
thereby making increasing the difficulty of extraction [99]. This apparent binding effect
made it necessary to use chitosanase and collagenase to digest the chitosan/gelatin gels.
In the case of the collagen gel samples, the gel fragments clogged the spin column,
preventing the effective release of RNA during the extraction process. Hence the collagen
gel samples were digested using collagenase prior to RNA extraction.
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The extraction procedure for RNA consisted of a combination of the TRIzol®
method and RNeasy Mini Kit method. The TRIzol® reagent contains a mixture of
guanidinium isothiocyanate which is responsible for inactivation of RNases and
phenol/chloroform which enables the phase separation of proteins and RNA. The
TRIzol® method of RNA extraction is considered more sensitive than other methods of
RNA extraction [100]. Hence, for collagen and chitosan/gelatin gel samples, this method
of extraction was followed.
The RNA quantification using the 2100 Agilent Bioanalyzer did not yield any
RIN number or 28s/18s ratio. This bioanalyzer is capable of accurately detecting total
RNA of 10-500ng/µL and requires a minimum of 25ng/µL for quantification [101].
However, below this range, it is not possible to accurately quantify RNA. Because of the
difficulty involved in RNA extraction due to low cell numbers and presence of hydrogels,
very low quantities of RNA was obtained, lower than the preferable range of the
Bioanalyzer. This resulted in low or no RIN values for the samples. Also no values were
obtained for the 28s/18s ratio that assesses RNA integrity and purity. It must be noted
that because of the lack of RIN values and rRNA ratios, it was not possible to determine
whether intact or degraded RNA has been extracted.
The Ct (cycle threshold) value obtained from the PCR represents the number of
cycles required for the fluorescence signal to cross the threshold value. To calculate
quantitative results, the Ct value for the housekeeping gene (GAPDH) must be consistent
between all the samples. However, the difference between the Ct values of the samples
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was as high as 4 cycles. The low quantities of RNA extracted caused an inaccurate
quantification, causing a difference in the starting RNA concentration between the
samples during PCR, subsequently causing the differences in the Ct values for GAPDH.
However for the purpose of these calculations, the average of the Ct value for GAPDH
was considered and all the calculations were completed.
C/EBP-α is an early marker of adipocyte differentiation that is expressed at the
onset of differentiation. The inhibition of C/EBP-α has been shown to prevent the
differentiation of preadipocytes, indicating the importance of this gene [102]. Figure
2.15 shows that, in almost all the samples, the expression of C/EBP-α is low and in some
samples, nonexistent. This outcome is likely because the expression of this gene is
reduced significantly after 5 days, and our samples were analyzed after 6 days.
PPAR-γ, an intermediate adipogenesis marker is considered solely adiposespecific. This gene is activated by the presence of long chain fatty acids and other fatty
acid metabolites [102]. The higher expression of PPAR-γ observed in the presence of
NMuMGs could be as a result of the cellular factors released by these cells. Similarly
higher expression of aP-2 was seen in the samples where D1 cells were in the presence of
NMuMGs. Several studies resulted in increased mammary epithelial cell proliferation
due to the presence of stromal cells [103] but the influence of epithelial cell on
differentiation has not been analyzed in detail. Studies by Xu and coworkers have shown
that when murine stromal cells are cultured with conditioned medium from murine
mammary epithelial cells, adipocyte differentiation is not inhibited. Contrasting evidence
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has been provided by Julianelli and coworkers, who have shown inhibition of
adipogenesis of murine 3T3-L1 cells in the presence of murine mammary epithelial cells
[104]. The 3T3-L1 cells have been shown to produce and activate TGF-β, a potent
inhibitor of adipogenesis, which may be responsible for the difference in results [105].
Cellular cytokines affect the adipogenesis of cells. Factors such as tumor necrosis
factor-α (TNF-α), transforming growth factor-β (TGF-)β, interleukin-11 (IL-11) have
been shown to inhibit adipogenesis in 3T3-L1 cells. A study by Yang and coworkers
suggested that increased levels of plasminogen activator was seen along with reduced
levels of lipid produced when murine D1 cells were treated to bovine MAC-T
conditioned medium, and reduced levels of plasminogen activator was seen in
conjunction with increased lipid production seen when D1 cells were treated with murine
NMuMG conditioned medium [106]. These results strongly suggest the release of certain
soluble cytokines by the NMuMGs which influence the differentiation of D1s.
The relative gene expression followed a similar pattern in case of the pipetted and
printed samples. However differences in the levels of gene expression were seen. These
differences could be because of the use of an average GAPDH value for the samples
rather than the actual value. While calculating the relative gene expression, a difference
of two cycles in the Ct value can cause marked difference in the gene expression value.
Hence the use of an average value of the housekeeping gene could be responsible for the
differences observed.
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CONCLUSIONS
The results provide the preliminary information necessary for the development of
a three-dimensional test system using inkjet printing. Prior to using inkjet printing for
biofabrication, the cell output from the printer was studied. The studies showed variation
in the cell settling data, specific to the cell type. On average, one cell was printed per
drop and two cells were printed per drop for D1s and NMuMGs respectively. Cell output
increased with increase in printing time and initial cellular concentration.
Lipid analysis showed a slight increase in lipid production in the presence of
NMuMGs for the pipetted group. In the printed group, all the substrates showed similar
lipid production levels. An increased gene expression of the intermediate (PPAR-γ) was
seen in collagen and chitosan/gelatin samples where D1 cells were cultured alone in the
printed group. An increased gene expression of the late marker of adipogenesis (aP-2)
was observed in the presence of mammary epithelial cells with higher gene expression in
samples which the NMuMGs were at a distance. This was observed in both the collagen
and the chitosan/gelatin samples for the printed and the pipetted groups. The expression
of early markers of adipogenesis was absent in all the samples.
These results provide a foundation for developing a three-dimensional breast
tissue model consisting of many cell and material components. With increased
knowledge of the interactions between the various components of the system and
refinement of the system, the inkjet printer will be capable of constructing such a
complex three-dimensional system.
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RECOMMENDATIONS
Future studies must be conducted to test the efficiency of the HP 26 cartridges used in
printing. The effect of the cleaning procedure and sonication on the cartridges must
be assessed.
The properties of the chitosan-based ink must be measured. Further research should
be conducted to develop a gelling method for chitosan ink post-printing to facilitate
the creation of three-dimensional scaffolds.
The cell interaction study should be repeated with larger cell numbers that yield
greater quantities of RNA. The PCR study must be repeated to confirm the
housekeeping gene values and to confidently identify the presence of other
adipogenesis markers such as GAPP-13. The differences in the gene expression of
NMuMGs/D1 samples with cells printed in close proximity and at a distance must be
quantified. The samples should be tested for the levels of soluble cytokines such as
TGF-β, TNF-α expressed by NMuMGs which can help further understand the effects
of distance and proximity on the adipogenesis of D1 cells.
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